Mohanraj Manangeeswaran, PhD

Senior Research Scientist
US FDA
Silver Spring, Maryland, United States

Presentation(s):

• Immunogenicity Risk Assessment: Are Preclinical Methods Informative? (S03)

  Monday, November 18, 2024
  9:00 AM – 12:00 PM CT

• Testing Process and Product Related Impurities to Inform Immunogenicity Risk (S03-5)

  Monday, November 18, 2024
  11:15 AM – 11:45 AM CT